Prevalence of overweight and obesity in Irish school children, using four different definitions

J L O'Neill1, S N McCarthy, S J Burke

  • 1School of Agriculture, Food Science and Veterinary Medicine, College of Life Sciences, University College Dublin, Republic of Ireland.

Insights

Overweight and obesity are prevalent in Irish children, with rates varying by assessment method. Obesity has significantly increased in children aged 8-12 years between 1990 and 2005.

Area of Science:

  • Pediatric Public Health
  • Nutritional Epidemiology
  • Childhood Obesity Research

Background:

  • Childhood overweight and obesity represent a significant global public health concern.
  • Accurate prevalence data is crucial for effective public health interventions.
  • Previous national data in Ireland requires updated assessment using standardized methodologies.

Purpose of the Study:

  • To determine the prevalence of overweight and obesity in Irish children.
  • To compare prevalence estimates using four distinct weight-for-height assessment methods.
  • To examine secular trends in childhood obesity from 1990 to 2005.

Main Methods:

  • A cross-sectional survey was conducted in the Republic of Ireland between 2003 and 2004.
  • Weight and height were measured in a random sample of 596 children aged 5-12 years.
  • Prevalence was calculated using four methods: actual relative weight, CDC BMI-for-age charts, UK 1990 BMI curves, and IOTF cutoffs.

Main Results:

  • Prevalence estimates for overweight and obesity varied significantly across the four methods.
  • Obesity prevalence ranged from 4.1% to 11.2% in boys and 9.3% to 16.3% in girls.
  • A two-to-fourfold increase in obesity was observed in children aged 8-12 years between 1990 and 2005.

Conclusions:

  • There is a clear need for a standardized definition of childhood obesity in Ireland due to methodological variations.
  • The study confirms a high prevalence of overweight and obesity among Irish school children.
  • The substantial increase in obesity prevalence over 15 years underscores a critical and growing public health issue.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...